1st Quarter - Report

ARTHRITIS FOUNDATION for ARTHRITIS FOUNDATION

Period 1st Quarter 2008 Filed May 19, 2008 Signed by Kristin St. John, Grassroots Advocacy Coordinator

Official filing
Firm
ARTHRITIS FOUNDATION
Client
ARTHRITIS FOUNDATION
Income
—
Expenses
$133,393
Expense method
B: tax-exempt organisations, Internal Revenue Code section 6033(b)(8)

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Advocate for increased appropriations for the Center for Disease Control & Prevention and the National Institues of Health Provided comments on following bills: Patient Protection and Innovative Biologic Medicines Act (H.R. 1956) Pathway for Biosimilars Act (H.R. 5629) Access to Life-Saving Medicine Act (H.R. 1038) Biologics Price Competition and Innovation (S. 1695)

LobbyistCovered position, as disclosed
AMY MELNICK —
JENNIFER NIETO CAREY —
JENNIFER TAYLOR MCBRIDE —
DAVID ZOOK —

Contacted: Centers For Disease Control & Prevention (CDC); SENATE; Health & Human Services, Dept of (HHS); Natl Institutes of Health (NIH); HOUSE OF REPRESENTATIVES

Bills named: H.R. 1038 (110th), S. 1695 (110th), H.R. 1956 (110th), H.R. 5629 (110th)

Medical/Disease Research/Clinical Labs MED

Support for and passage of the Arthritis Prevention, Control & Cure Act (S.626/H.R. 1283)

LobbyistCovered position, as disclosed
AMY MELNICK —
JENNIFER NIETO CAREY —
JENNIFER TAYLOR MCBRIDE —
DAVID ZOOK —

Contacted: Natl Institutes of Health (NIH); Centers For Disease Control & Prevention (CDC); HOUSE OF REPRESENTATIVES; SENATE; Health & Human Services, Dept of (HHS)

Bills named: H.R. 1283 (110th), S. 626 (110th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.